Medical science is on the verge of making history, new drug in trial completely eradicated colorectal cancer

A new ray of hope is visible in the medical world. A medicine that has added a new chapter in the treatment of cancer.

A new ray of hope is visible in the medical world. A medicine that has added a new chapter in the treatment of cancer. A recent research has revealed that a new medicine has completely eradicated colorectal cancer. This discovery can prove to be a milestone in the history of medical science.

 

In a new clinical trial, a drug called Dostarlimab has shown a 100% success rate, making it a topic of discussion in the medical world. All of the 18 patients who took this drug were completely cured and there was no trace of cancer left in their bodies. This trial was conducted at Memorial Sloan Kettering Cancer Center in New York, USA.

 

Will this drug be effective for all cancer patients?

Experts believe that this breakthrough is important for patients with mismatch repair-deficient (dMMR) colorectal cancer, but it may not be as effective for all types of colorectal cancer. Dr. Pooja Babbar, Consultant of Medical Oncology at CK Birla Hospital, Gurugram, says that this trial has been done on a small scale and large-scale studies are necessary to confirm the long-term effectiveness of this drug.

How to prevent colorectal cancer?

Cases of colorectal cancer are increasing, especially in people under the age of 50. Experts say that this cancer can be prevented by timely screening, balanced diet, regular exercise, abstinence from tobacco and alcohol and adopting a diet rich in fiber. Since screening for this cancer usually happens after the age of 45, it is important for young people to pay attention to their health as well.

 

Disclaimer: Dear reader, thank you for reading this news. This news has been written only to make you aware. We have taken the help of general information in writing this. If you read anything related to your health anywhere, then definitely consult a doctor before adopting it.